These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7198328

  • 1. Estramustine phosphate with multiple cytotoxic agents in treatment of advanced prostatic cancer.
    Beckley S, Wajsman Z, Maeso E, Pontes E, Murphy G.
    Urology; 1981 Dec; 18(6):592-5. PubMed ID: 7198328
    [Abstract] [Full Text] [Related]

  • 2. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP, Slack NH, Mittelman A.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate.
    Soloway MS, deKernion JB, Gibbons RP, Johnson DE, Loening SA, Pontes JE, Prout GR, Schmidt JD, Scott WW, Chu TM, Gaeta JF, Slack NH, Murphy GP.
    J Urol; 1981 May; 125(5):664-7. PubMed ID: 7230336
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R, Kaufman J, Mittelman A, Murphy GP.
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [Abstract] [Full Text] [Related]

  • 5. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A, Zattoni F, Frustaci S, Galligioni E, Tirelli U, Trovó G, Tumolo S, Merlo A, Artuso G, Cosciani-Cunico S, Grigoletto E.
    Prostate; 1982 Mar; 3(2):159-64. PubMed ID: 7088731
    [Abstract] [Full Text] [Related]

  • 6. A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
    Soloway MS, Beckley S, Brady MF, Chu TM, deKernion JB, Dhabuwala C, Gaeta JF, Gibbons RP, Loening SA, McKiel CF, McLeod DG, Pontes JE, Prout GR, Scardino PT, Schlegel JU, Schmidt JD, Scott WW, Slack NH, Murphy GP.
    J Urol; 1983 Jan; 129(1):56-61. PubMed ID: 6338251
    [Abstract] [Full Text] [Related]

  • 7. The chemotherapy of prostatic adenocarcinoma.
    Torti FM, Carter SK.
    Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
    [Abstract] [Full Text] [Related]

  • 8. [The use of estramustine phosphate (estramustine, Estracyt) in Norway 1972-1981. An example of the irrational use of an expensive treatment].
    Fosså SD, Hovind OB, Hillestad B.
    Tidsskr Nor Laegeforen; 1984 Mar 10; 104(7):482-4. PubMed ID: 6729780
    [No Abstract] [Full Text] [Related]

  • 9. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH, Wajsman Z, Mittelman A, Bruno S, Murphy GP.
    Urology; 1979 Dec 10; 14(6):549-54. PubMed ID: 390810
    [Abstract] [Full Text] [Related]

  • 10. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A, Catane R, Murphy GP.
    Cancer Treat Rep; 1977 Dec 10; 61(2):307-10. PubMed ID: 872134
    [Abstract] [Full Text] [Related]

  • 11. Continuous versus intermittent oral therapy with estramustine phosphate (Estracyt).
    Vahlensieck W, Wegner G.
    Scand J Urol Nephrol Suppl; 1980 Dec 10; 55():147-9. PubMed ID: 6938018
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
    Herr HW.
    J Urol; 1982 Mar 10; 127(3):462-5. PubMed ID: 7062419
    [Abstract] [Full Text] [Related]

  • 14. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P, Bretaudeau B, Palangie T, Jouve M, Garcia-Giralt E, Asselain B.
    Bull Cancer; 1982 Mar 10; 69(5):434-42. PubMed ID: 6891903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
    Benson RC, Wear JB, Gill GM.
    J Urol; 1979 Apr 10; 121(4):452-4. PubMed ID: 439216
    [Abstract] [Full Text] [Related]

  • 17. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A, Shukla SK, Murphy GP.
    J Urol; 1976 Apr 10; 115(4):409-12. PubMed ID: 1263317
    [Abstract] [Full Text] [Related]

  • 18. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov 10; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J, Jung JL, Bittard M.
    J Urol (Paris); 1984 Nov 10; 90(1):27-33. PubMed ID: 6725973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.